• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA-MCM3AP-AS1通过增强miR-138-5p/HIF-1α轴调控的糖酵解促进婴儿血管瘤进展。

LncRNA-MCM3AP-AS1 Promotes the Progression of Infantile Hemangiomas by Increasing miR-138-5p/HIF-1α Axis-Regulated Glycolysis.

作者信息

Mei Haijun, Xian Hua, Ke Jing

机构信息

Department of General Surgery, Affiliated Hospital of Nantong University, Nantong, China.

出版信息

Front Mol Biosci. 2021 Sep 29;8:753218. doi: 10.3389/fmolb.2021.753218. eCollection 2021.

DOI:10.3389/fmolb.2021.753218
PMID:34660700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8511435/
Abstract

Infantile hemangioma (IH) is a common benign tumor of endothelial cells in infants. Most hemangiomas are self-limited, but a few may develop and lead to serious complications that affect the normal life of children. Therefore, finding an effective treatment strategy for IH is a pressing need. Recent studies have demonstrated that non-coding RNAs affect the progression of multiple tumors. This study aims to investigate the mechanism by which LncRNA-MCM3AP-AS1 promotes glycolysis in the pathogenesis of IH. We first documented that the expression of LncRNA MCM3AP-AS1 was significantly upregulated in IH. Furthermore, we demonstrated that MCM3AP-AS1 bound to miR-106b-3p which promotes glycolysis in IH. In addition, we found that inhibition of HIF-1α contributed to the transformation of glycolysis to normal aerobic oxidation, partially reversed the promoting effect on glycolysis by the up-regulation of LncRNA MCM3AP-AS1 in IH disease. More importantly, we demonstrated this phenomenon existed in IH patients. Taken together, we demonstrate that LncRNA-MCM3AP-AS1 promotes the progression of infantile hemangiomas by increasing the glycolysis via regulating miR-138-5p/HIF-1α axis.

摘要

婴儿血管瘤(IH)是婴儿常见的内皮细胞良性肿瘤。大多数血管瘤是自限性的,但少数可能发展并导致严重并发症,影响儿童的正常生活。因此,寻找一种有效的IH治疗策略迫在眉睫。最近的研究表明,非编码RNA影响多种肿瘤的进展。本研究旨在探讨长链非编码RNA-MCM3AP-AS1在IH发病机制中促进糖酵解的机制。我们首先记录到,长链非编码RNA MCM3AP-AS1在IH中的表达显著上调。此外,我们证明MCM3AP-AS1与促进IH中糖酵解的miR-106b-3p结合。此外,我们发现抑制缺氧诱导因子-1α(HIF-1α)有助于糖酵解转变为正常的有氧氧化,部分逆转了长链非编码RNA MCM3AP-AS1上调对IH疾病中糖酵解的促进作用。更重要的是,我们证明这种现象在IH患者中存在。综上所述,我们证明长链非编码RNA-MCM3AP-AS1通过调节miR-138-5p/HIF-1α轴增加糖酵解,从而促进婴儿血管瘤的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/010f96b8bf95/fmolb-08-753218-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/cd0188d08f7d/fmolb-08-753218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/8fe0cfb13238/fmolb-08-753218-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/227ce478d878/fmolb-08-753218-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/d15c1b86ce10/fmolb-08-753218-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/f5af9e02bfe2/fmolb-08-753218-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/3c7091010434/fmolb-08-753218-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/010f96b8bf95/fmolb-08-753218-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/cd0188d08f7d/fmolb-08-753218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/8fe0cfb13238/fmolb-08-753218-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/227ce478d878/fmolb-08-753218-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/d15c1b86ce10/fmolb-08-753218-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/f5af9e02bfe2/fmolb-08-753218-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/3c7091010434/fmolb-08-753218-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e4e/8511435/010f96b8bf95/fmolb-08-753218-g007.jpg

相似文献

1
LncRNA-MCM3AP-AS1 Promotes the Progression of Infantile Hemangiomas by Increasing miR-138-5p/HIF-1α Axis-Regulated Glycolysis.长链非编码RNA-MCM3AP-AS1通过增强miR-138-5p/HIF-1α轴调控的糖酵解促进婴儿血管瘤进展。
Front Mol Biosci. 2021 Sep 29;8:753218. doi: 10.3389/fmolb.2021.753218. eCollection 2021.
2
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.一种新型长链非编码 RNA MCM3AP-AS1 通过靶向 miR-194-5p/FOXA1 轴促进肝癌的生长。
Mol Cancer. 2019 Feb 19;18(1):28. doi: 10.1186/s12943-019-0957-7.
3
LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis.长链非编码 RNA MCM3AP-AS1 通过调节 miR-28-5p/CENPF 轴促进乳腺癌进展。
Biomed Pharmacother. 2020 Aug;128:110289. doi: 10.1016/j.biopha.2020.110289. Epub 2020 May 30.
4
LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.长链非编码 RNA MCM3AP-AS1 通过调控 miR-211-5p/SPARC 轴促进甲状腺乳头状癌细胞的增殖和侵袭。
Endocrine. 2019 Aug;65(2):318-326. doi: 10.1007/s12020-019-01939-4. Epub 2019 Apr 27.
5
LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer.长链非编码RNA MCM3AP-AS1通过调控miR-543-3p/SLC39A10/PTEN轴促进前列腺癌细胞增殖和侵袭
Onco Targets Ther. 2020 Sep 22;13:9365-9376. doi: 10.2147/OTT.S245537. eCollection 2020.
6
LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p/RBM39 axis.长链非编码RNA MCM3AP-AS1通过miR-524-5p/RBM39轴促进三阴性乳腺癌的化疗耐药性。
Mol Cell Biochem. 2025 Jan;480(1):371-384. doi: 10.1007/s11010-023-04908-8. Epub 2024 Mar 12.
7
LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.长链非编码 RNA MCM3AP-AS1 通过调节 miR-204-5p/FOXC1 促进口腔鳞状细胞癌细胞的增殖、迁移和侵袭。
J Investig Med. 2020 Oct;68(7):1282-1288. doi: 10.1136/jim-2020-001415. Epub 2020 Jul 19.
8
A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progression.MCM3AP-AS1在肿瘤发生和肿瘤进展中的作用综述。
Cancer Cell Int. 2022 Jul 5;22(1):225. doi: 10.1186/s12935-022-02644-5.
9
lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p.长链非编码RNA MCM3AP-AS1通过抑制miR-363-5p促进口腔鳞状细胞癌的发展。
Exp Ther Med. 2020 Aug;20(2):978-984. doi: 10.3892/etm.2020.8738. Epub 2020 May 12.
10
YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis.YY1 介导的长链非编码 RNA MCM3AP-AS1 的过表达通过靶向 miR-340-5p/KPNA4 轴促进肺癌血管生成和进展。
J Cell Biochem. 2020 Mar;121(3):2258-2267. doi: 10.1002/jcb.29448. Epub 2019 Nov 6.

引用本文的文献

1
Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors.缺氧驱动的血管肿瘤血管生成与代谢重编程
Front Cell Dev Biol. 2025 May 15;13:1572909. doi: 10.3389/fcell.2025.1572909. eCollection 2025.
2
Overexpression of Long Non-coding RNAs and Predict Poor Prognosis in Patients with Gastric Adenocarcinoma.长链非编码RNA过表达与胃腺癌患者预后不良相关
Adv Biomed Res. 2024 Apr 27;13:34. doi: 10.4103/abr.abr_308_23. eCollection 2024.
3
IL13RA2 promotes progression of infantile haemangioma by activating glycolysis and the Wnt/β-catenin signaling pathway.

本文引用的文献

1
Photothermal Responsive Singlet Oxygen Nanocarriers for Hypoxic Cancer Cell Ablation.光热响应型单线态氧纳米载体用于乏氧肿瘤细胞消融。
Chembiochem. 2021 Aug 3;22(15):2546-2552. doi: 10.1002/cbic.202100098. Epub 2021 Jun 22.
2
MnO nanosheets anchored with polypyrrole nanoparticles as a multifunctional platform for combined photothermal/photodynamic therapy of tumors.MnO 纳米片锚定聚吡咯纳米粒子作为肿瘤光热/光动力联合治疗的多功能平台。
Food Funct. 2021 Jul 21;12(14):6334-6347. doi: 10.1039/d1fo00032b. Epub 2021 Jun 8.
3
A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism.
IL13RA2 通过激活糖酵解和 Wnt/β-catenin 信号通路促进婴儿血管瘤的进展。
Oncol Res. 2024 Aug 23;32(9):1453-1465. doi: 10.32604/or.2024.048315. eCollection 2024.
4
Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1).EZH2/miR-138-5p 轴失调通过下调低氧诱导因子 1 ɑ(HIF-1ɑ)促进肝癌细胞放射敏感性。
Oxid Med Cell Longev. 2022 Aug 29;2022:7608712. doi: 10.1155/2022/7608712. eCollection 2022.
5
Long Non-Coding RNA MCM3AP-AS1: A Crucial Role in Human Malignancies.长链非编码 RNA MCM3AP-AS1:在人类恶性肿瘤中的关键作用。
Pathol Oncol Res. 2022 Jun 16;28:1610194. doi: 10.3389/pore.2022.1610194. eCollection 2022.
6
ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.ALKBH5 通过调控 NEAT1/miR-378b/FOSL1 轴促进婴幼儿血管瘤的进展。
Mol Cell Biochem. 2022 May;477(5):1527-1540. doi: 10.1007/s11010-022-04388-2. Epub 2022 Feb 18.
HIF1α-GPD1 正反馈环路通过线粒体功能和脂质代谢抑制肾透明细胞癌的进展。
J Exp Clin Cancer Res. 2021 Jun 7;40(1):188. doi: 10.1186/s13046-021-01996-6.
4
Hypoxia is a key regulator in liver cancer progression.缺氧是肝癌进展的关键调节因子。
J Hepatol. 2021 Sep;75(3):736-737. doi: 10.1016/j.jhep.2021.05.032. Epub 2021 Jun 19.
5
Side-Chain Selenium-Grafted Polymers Combining Antiangiogenesis Treatment with Photodynamic Therapy and Chemotherapy.将抗血管生成治疗与光动力疗法及化疗相结合的侧链硒接枝聚合物
ACS Biomater Sci Eng. 2021 Jul 12;7(7):3201-3208. doi: 10.1021/acsbiomaterials.1c00254. Epub 2021 Jun 7.
6
Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B.肿瘤来源的外泌体 miR-138-5p 通过抑制 KDM6B 来调节肿瘤相关巨噬细胞的极化。
Theranostics. 2021 May 3;11(14):6847-6859. doi: 10.7150/thno.51864. eCollection 2021.
7
Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling.低氧肿瘤来源的外泌体 miR-31-5p 通过负调控 SATB2 逆转的 EMT 和激活 MEK/ERK 信号促进肺腺癌转移。
J Exp Clin Cancer Res. 2021 Jun 1;40(1):179. doi: 10.1186/s13046-021-01979-7.
8
Depletion of Circular RNA circ_CORO1C Suppresses Gastric Cancer Development by Modulating miR-138-5p/KLF12 Axis.环状RNA circ_CORO1C的缺失通过调节miR-138-5p/KLF12轴抑制胃癌发展。
Cancer Manag Res. 2021 May 11;13:3789-3801. doi: 10.2147/CMAR.S290629. eCollection 2021.
9
Curcumin suppresses renal carcinoma tumorigenesis by regulating circ-FNDC3B/miR-138-5p/IGF2 axis.姜黄素通过调控 circ-FNDC3B/miR-138-5p/IGF2 轴抑制肾细胞癌发生。
Anticancer Drugs. 2021 Aug 1;32(7):734-744. doi: 10.1097/CAD.0000000000001063.
10
microRNAs: New-Age Panacea in Cancer Therapeutics.微小RNA:癌症治疗中的新时代万灵药
Indian J Surg Oncol. 2021 Apr;12(Suppl 1):52-56. doi: 10.1007/s13193-020-01110-w. Epub 2020 Jun 6.